Hana Chen-Walden
Nessuna posizione attualmente
Storia della carriera di Hana Chen-Walden
Precedenti posizioni note di Hana Chen-Walden
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOXYTRAN, INC. | Direttore/Membro del Consiglio | - | 19/04/2024 |
| Independent Dir/Board Member | - | 19/04/2024 | |
| Covalent Group, Inc. | Consigliere Generale | 01/01/2003 | 01/01/2003 |
| NANOMIX CORPORATION | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Hana Chen-Walden
| Tel-Aviv University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Israele | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| General Counsel | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOXYTRAN, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
| Covalent Group, Inc. | Commercial Services |
- Borsa valori
- Insiders
- Hana Chen-Walden
- Esperienza
